Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity

OBJECTIVE: To compare post-treatment recurrence between ranibizumab injection and laser photocoagulation (LP) for type 1 retinopathy of prematurity (ROP), and explore the associated risk factors. METHODS: The clinical data of ROP infants treated with LP or ranibizumab in a NICU of China from October...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jing-Ke, Han, Tao, Tang, Hong-Yi, Zhang, Sheng, Wang, Zong-Hua, Feng, Zhi-Chun, Li, Qiu-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071726/
https://www.ncbi.nlm.nih.gov/pubmed/37016343
http://dx.doi.org/10.1186/s12886-023-02886-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071726/
https://www.ncbi.nlm.nih.gov/pubmed/37016343
http://dx.doi.org/10.1186/s12886-023-02886-5

Ejemplares similares